Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Brain Biosciences, Inc.
- Proposal award date
- 2015-09-15
- Contract end date
- 2019-08-31
- UEI
- PFWBBNMA5LN7
- Solicitation number
- PAR14-088
- Topic code
- NIDA
Research abstract
DESCRIPTION provided by applicant Advanced imaging technologies such as Positron Emission Tomography PET and Magnetic Resonance Imaging MR have led to remarkable improvement in our knowledge of brain metabolism function and biochemistry And yet our understanding of most neurological disorders is at best rudimentary Etiology of such common diseases as drug and alcohol addiction schizophrenia Alzheimerandapos s dementia and Parkinsonandapos s remains elusive Malignant brain tumors such as glioblastoma continue being fatal Changes happening in the brain in such common syndromes as hospital acquired delirium and post operative cognitive decline are not understood Most studies involving advanced brain imaging remain small due to logistical challenges cost constraints and difficulty of scanning neurological patients in standard radiology equipment Acceleration of brain research is required to elucidate the pathophysiology of neurological and psychiatric conditions Brain Biosciences was established to make neurological imaging comfortable inexpensive and widely available both in the clinic and in the research laboratory One of the common problems encountered in imaging research is unintentional patient motion Head movement during Positron Emission Tomography PET degrades PET image quality leads to image artifacts and introduces quantitative errors Motion is particularly common in confused patients with neurological diseases drug addiction and movement disorders This problem becomes especially relevant as research involving lengthy dynamic scans and high resolution brain imaging becomes common While sedation is often used to minimize the patient motion sedative drugs change brain biochemistry interfere with radiopharmaceutical uptake and may cause side effects Physical restraints are often distressing and may increase patient agitation In this direct Phase
II SBIR proposal we seek to develop clinically validate and receive FDA clearance for FREEMotion tm a video based head tracking system enabling motion compensated brain Positron Emission Tomography PET imaging of neurological patients without sedation or physical head restraint PUBLIC HEALTH RELEVANCE This application proposes to develop and validate a novel head tracking system capable of compensating for patient motion during high resolution brain Positron Emission Tomography PET imaging This device will lower improve the quality comfort and quantification of brain PET in patients with neurological and psychiatric diseases as well as drug abuse The proposed device will have applications both in the clinic and neuroscience research
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
Research funding history
3 SBIR/STTR records share this UEI (2013–2015). Reported award amounts total $3,591,615. Reported amounts are not federal obligations.
Phases: Phase II, Phase I, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards